Share

The TEAM Study – Treatment Efficacy for Autism/Attention using Mixed Amphetamine Salts

Study Flyer:
Eligibility Criteria:
WHO:

Researchers: Dr. Gagan Joshi
Institution: Massachusetts General Hospital

WHAT:

Treatment Efficacy for Autism/Attention

WHERE:

Boston, MA

RECRUITMENT ENDS:

2026-06-23

Interested?

Contact:

Meredith

Call (617) 724-7301

What's the study about?

A 10-week study evaluating whether a commonly prescribed ADHD medication (mixed amphetamine salts/Adderall) safely and effectively reduces ADHD symptoms in intellectually intact youth with ASD. The study includes screening, a randomized double-blind medication phase, and brain imaging before and after treatment to better understand clinical and neural effects. Participants may receive compensation, and parking costs are covered.

Who can participate?

Children From ages 8-18

What will participants be doing?

The study includes screening, a randomized double-blind medication phase, and brain imaging before and after treatment to better understand clinical and neural effects.

Why is this important?

This study will help researchers better understand how the use of MAS to treat ADHD effects children and adolescents with ASD.

Research Study Website
The TEAM Study